التفاصيل البيبلوغرافية
العنوان: |
Relationship between alirocumab, PCSK9, and LDL-C levels in four phase 3 ODYSSEY trials using 75 and 150 mg doses |
المؤلفون: |
Robinson, Jennifer G., Farnier, Michel, Kastelein, John J.P., Roth, Eli M., Taskinen, Marja-Riitta, Colhoun, Helen M., Brunet, Aurelie, DiCioccio, A. Thomas, Lecorps, Guillaume, Pordy, Robert, Baccara-Dinet, Marie T., Cannon, Christopher P. |
المصدر: |
In Journal of Clinical Lipidology November-December 2019 13(6):979-988 |
قاعدة البيانات: |
ScienceDirect |